Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 27:4:JGO.18.00180.
doi: 10.1200/JGO.18.00180. eCollection 2018.

Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network

Affiliations

Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network

Mahmoud Salama et al. J Glob Oncol. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] JCO Glob Oncol. 2022 Mar;8:e2100417. doi: 10.1200/GO.21.00417. JCO Glob Oncol. 2022. PMID: 35275737 Free PMC article. No abstract available.

Corrected and republished in

Abstract

Purpose: Oncofertility practice continues to grow in developing countries despite the lack of health care services, especially those related to cancer care. The purpose of this study is to further explore oncofertility practice in these countries and identify opportunities for field-wide coalescence.

Methods: We generated a survey to learn more about oncofertility practice in nine developing countries within our Oncofertility Consortium Global Partners Network-Mexico, Colombia, Guatemala, Argentina, Chile, Nigeria, South Africa, Saudi Arabia, and India. Their responses were collected, reviewed, and discussed.

Results: Surveyed centers from the nine developing countries continue to experience a similar set of common challenges, including a lack of awareness among providers and patients, cultural and religious constraints, lack of insurance coverage and funding to help to support oncofertility programs, and high out-of-pocket costs for patients. Despite these barriers, many opportunities exist and there is great potential for the future.

Conclusion: The current need is to unify the new technologies and best practices that emerge from rural communities and developing countries with those in large metropolitan cities, both domestically (US based) and abroad, into a functional unit: the Oncofertility Professional Engagement Network. The Oncofertility Professional Engagement Network will bridge the gap between domestic and international programs to establish a strong global network in which members share resources, methodologies and experiences and further build cultural competency.

PubMed Disclaimer

Conflict of interest statement

Fabio Sobral

Travel, Accommodations, Expenses: Merck Serono

Maria T. Bourlon

Honoraria: Tecnofarma

Consulting or Advisory Role: Bristol-Myers Squibb, Asofarma, Eisai, MSD Oncology, Janssen Oncology, Novartis, Bayer

Speakers' Bureau: Asofarma, MSD Oncology, Bristol-Myers Squibb, Bayer, Eisai, Janssen Oncology, Ipsen

Expert Testimony: Asofarma

Travel, Accommodations, Expenses: Asofarma, Janssen-Cilag, MSD Oncology

Satish Kumar Adiga

Consulting or Advisory Role: Manipal Embryology Consultancy Service (Inst)

Research Funding: Merck Serono (Inst)

Karthik S. Udupa

Research Funding: ICON/Pfizer-sponsored trial

Georgia Demetriou

Honoraria: Genentech

Consulting or Advisory Role: AstraZeneca, Profmed Medical Aid

Speakers' Bureau: Merck Serono

Travel, Accommodations, Expenses: Key Oncologics, Merck Serono

Gabriela Rodriguez

Travel, Accommodations, Expenses: Ferring

Tomas Quintana

Travel, Accommodations, Expenses: Ferring

July Andrea Russi Noguera

Research Funding: Bristol-Myers Squibb

Travel, Accommodations, Expenses: Novartis

Juan Carlos Velásquez Velásquez

Consulting or Advisory Role: Tecnofarma

Research Funding: Bristol-Myers Squibb, Ciber

No other potential conflicts of interest were reported.

Figures

FIG 1
FIG 1
Merger of domestic and global networks in to one unified network, the Oncofertility Professional Engagement Network.

Similar articles

Cited by

References

    1. Ataman LM, Rodrigues JK, Marinho RM, et al. : Creating a global community of practice for oncofertility. J Glob Oncol doi:10.1200/JGO.2015.000307 - DOI - PMC - PubMed
    1. Rashedi A, de Roo SF, Ataman L, et al. : A survey of fertility preservation options available to cancer patients around the globe. J Glob Oncol doi:10.1200/JGO.2016.008144 - DOI - PMC - PubMed
    1. Rashedi A, de Roo SF, Ataman L, et al. : A survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. J Glob Oncol doi:10.1200/JGO.2017.009944 - DOI - PMC - PubMed
    1. Salama M, Ataman L, Taha T, et al. : Building oncofertility core competency in developing countries: Experience from Egypt, Tunisia, Brazil, Peru, and Panama. J Glob Oncol doi:10.1200/JGO.17.00121 - DOI - PMC - PubMed
    1. United Nations : Human development reports: Global human development indicators. http://hdr.undp.org/en/countries

Publication types